WHO Recommends Two New Drugs To Treat COVID-19

- Advertisement -

Press Release:-  WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be.

The first drug, baricitinib, is strongly recommended for patients with severe or critical COVID-19. It is part of a class of drugs called Janus kinase (JAK) inhibitors that suppress the overstimulation of the immune system. WHO recommends that it is given with corticosteroids.

Baricitinib is an oral drug, used in the treatment of rheumatoid arthritis. It provides an alternative to other arthritis drugs called Interleukin-6 receptor blockers, recommended by WHO in July 2021.

WHO has also conditionally recommended the use of a monoclonal antibody drug, sotrovimab, for treating mild or moderate COVID-19 in patients who are at high risk of hospitalization. This includes patients who are older, immunocompromised, having underlying conditions like diabetes, hypertension, and obesity, and those unvaccinated.

- Advertisement -

Sotrovimab is an alternative to casirivimab-imdevimab, a monoclonal antibody cocktail recommended by WHO in September 2021. Studies are ongoing on the effectiveness of monoclonal antibodies against Omicron but early laboratory studies show that sotrovimab retains its activity.

The panel of experts developing the guidelines also looked at two other drugs for severe and critical COVID-19: ruxolitinib and tofacitinib. Given their uncertain effects, WHO made a conditional recommendation against their use.

Today’s recommendations, forming the eighth update of WHO’s living guidelines on therapeutics and COVID-19, are based on evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical COVID-19.

WHO is in discussions with manufacturers to secure global supply capacity and equitable and sustainable access to the newly recommended therapeutics. The Access to COVID-19 Tools Accelerator (ACT-A) Therapeutics pillar has been engaging with pharmaceutical companies to seek comprehensive access plans for low- and middle-income countries, so that these treatments can be rapidly deployed everywhere, not just in rich countries. The ACT-A is also looking to expand licensing scope to make the products more affordable.

The two newly recommended drugs – baricitinib and sotrovimab – have been invited for WHO Prequalification, which assesses the quality, efficacy and safety of priority health products to increase access in lower income countries.

- Advertisement -
Editorial Staff
Editorial Staff
Our Editorial Staff at St. Lucia Times is a team publishing news and other articles to over 200,000 regular monthly readers in Saint Lucia and in over 150 other countries worldwide.

4 COMMENTS

  1. Here again we see the use of repurposed drugs. Something manufactured for treatment of persons with Rheumatoid arthritis is now being used for treating Covid patients. Nothing wrong with that as doctors the world over have done so for years with much success. Then why not permit doctors to continue doing what they do best – having the latitude to discuss possible treatments with their patients without interference. Why is ivermectin not giving the same latitude for use after no fewer than forty studies have shown that it works. While it is an antiparasitic drug, like Baricitinib, it has proven that it is effective against the Covid virus. So why not approve its use. But they won’t because it is no longer patented and there is no money to be made by the greedy Joes. Fortunately, we can read and do not need their approval for experimenting with Ivermectin – and trust me when I say it works! Both as a prophylaxis (to prevent) and for early treatment of Covid. How do I know? – because I use it! And have done so with much success! It has also saved the lives of some close friends. So my fellow country people, welcome to my world. Do anything you can and have to stay alive. Ivermectin won’t kill you like has been suggesting by the fake news media. With over 40 years of being on the market and well over 40 billion doses being dispensed with very little adverse reactions, one can’t ask for a safer drug. Can’t say the same for the Covid injections though.

  2. Good news for the world, let’s start treatment of the whole world and get back to some sort of mortality

  3. So everything W.H.O says they right?Cocaine works too but that’s high risk of the whole world becoming a jombie.

Comments are closed.

TRENDING

spot_img

Subscribe to our St. Lucia Times Newsletter

Get our headlines emailed to you every day.

spot_img
RSLPF Investigates Castries Suicide ReportRead
+ +
Send this to a friend